Auxiliary partial orthotopic liver transplantation for Crigler-Najjar syndrome type 1

Annals of Surgery

Volumn 229, Issue 4, 1999, Pages 565-569

  Rela, Mohamed ^a   Muiesan, Paolo ^a   Vilca Melendez, Hector ^a   Dhawan, Anil ^a   Baker, Alaster ^a   Mieli Vergani, Giorgina ^a   Heaton, Nigel David ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; TACROLIMUS;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CRIGLER NAJJAR SYNDROME; ENZYME DEFECT; GRAFT REJECTION; HUMAN; LIVER CELL; LIVER TRANSPLANTATION; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

ADOLESCENT; BILIRUBIN; CHILD; CRIGLER-NAJJAR SYNDROME; HUMANS; LIVER TRANSPLANTATION;

EID: 0033509873     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199904000-00017     Document Type: Article

References (27)

1. Dubois RS, Rodgerson DO, Martineau G, et al. Orthotopic liver transplantation for Wilson's disease. Lancet 1971; 1:505-508.
2. Fisch RO, McCabe ERB, Doeden D, et al. Homotransplantation of the liver in a patient with hepatoma in hereditary tyrosinemia. J Pediatr 1978; 93:592-596.
3. Putnam CW, Porter KA, Peters RL, Ashcavai M, Redeker AG, Starzl TE. Liver replacement for alpha-1-antitrypsin deficiency. Surgery 1977; 81:258-261.
4. Kaufman S, Wood RP, Shaw BW, et al. Orthotopic liver transplantation for type I Crigler-Najjar syndrome. Hepatology 1986; 6:1259-1262.
5. Bilheimer DW, Goldstein JL, Grundy SM, Starzl TE, Brown MS. Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med 1984; 311:1658-1664.
6. Grodischer R, Levy G, Crasner J, Yaffe SJ. Congenital nonobstructive nonhemolytic jaundice. Effective phototherapy. N Engl J Med 1970; 282:375-377.
7. Yohannan MD, Terry HJ, Littlewood JM. Long-term phototherapy in Crigler-Najjar syndrome. Arch Dis Child 1983; 58:460-462.
8. Pett S, Mowat AP. Crigler-Najjar syndrome types I and II. Clinical experience, King's College Hospital 1972-1978. Phenobarbitone, phototherapy and liver transplantation. Mol Aspects Med 1987; 9:473-482.
9. Wolff H, Otto G, Giest H. Liver transplantation in Crigler-Najjar syndrome: a case report. Transplantation 1986; 42:84.
10. Sokal EM, Silva ES, Hermans D, et al. Orthotopic liver transplantation for Crigler-Najjar type 1 disease in six children. Transplantation 1995; 60:1095-1098.
11. Jansen PLM, Hess F, Peters WHM, Koenders E, Jerusalem C, Corstens FHM. Auxiliary liver transplantation in jaundiced rats with UDP-glucuronyltransferase deficiency and defective hepatobiliary transport. J Hepatol 1989; 8:192-200.
12. Blaschke TF, Berk PD, Scharschmidt BF, Guyther JR, Vergalla J, Waggoner JG. Crigler-Najjar syndrome: an unusual course with development of neurological disease at age 18 years. Pediatr Res 1974; 8:573-590.
13. Labrune PH, Myara A, Francoual J, Trivin F, Odievre M. Cerebellar symptoms as the presenting manifestations of bilirubin encephalopathy in children with Crigler-Najjar type I disease. Pediatrics 1992; 89:768-770.
14. Whittington PF, Edmond JC, Heffron TG, Thistelwaite JR. Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type 1. Lancet 1993; 342:779-780.
15. Mowat AP. Liver disorders in children: the indications for liver replacement m parenchymal and metabolic disease. Transplant Proc 1987; 19:3236-3241.
16. Raper SE Hepatocyte transplantation and gene therapy. Clin Transplant 1995; 9:249-254.
17. Tada K, Chowdhury NR, Neufeld D, et al. Long-term reduction of serum bilirubin levels in Gunn rats by retroviral gene transfer in vivo. Liver Transpl Surg 1998; 4:78-88.
18. Fox IJ, Chowdhury JR, Kaufman SS, et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998; 338:1422-1426.
19. Oldhafer KJ, Gubernatis G, Schlitt HJ, Rodeck B, Boker K, Pichlmayr R. Auxiliary partial orthotopic liver transplantation for acute liver failure: the Hannover experience. Clin Transpl 1994:181-187.
20. Chenard Neu MP, Boudjema K, Bernuau J, et al. Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure. A multicenter European study. Hepatology 1996; 23:1119-1127.
21. Rogiers X, Malago M, Habib N, et al. In situ splitting of the liver in the heart-beating cadaveric organ donor for transplantation in two recipients. Transplantation 1995; 59:1081-1083.
22. Veere CN van der, Sinaasappel M, McDonagh AF, et al. Current therapy for Crigler-Najjar Syndrome type 1: report of a world registry. Hepatology 1996; 24:311-315.
23. Jerusalem C, Heyde MN van der, Schmidt WJ, Tjebbes F. Heterotopic liver transplantation. Eur Surg Res 1972; 4:186-197.
24. Marchioro TL, Porter KA, Dickinson TC, Faris TD, Starzl TE. Physiologic requirements for auxiliary liver homotransplantation. Surg Gynecol Obstet 1965; 121:17-31.
25. Nagashima I, Bergmann L, Schweizer R. How can we share the portal blood inflow in auxiliary partial heterotopic liver transplantation without portal hypertension? Surgery 1994; 116:101-106.
26. Jamieson NV, Watts RWE, Evans DB, Williams R, Calne R. Liver and kidney transplantation in the treatment of primary hyperoxaluria. Transplant Proc 1991; 23:1557-1558.
27. Holmgren GH, Ericzon BG, Groth CG, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993; 341:1113-1116.